References
- Solomon T E. Control of exocrine pancreatic secretion. Physiology of the gastrointestinal tract. 2nd ed., L R Johnson. Raven Press, New York 1987; 1173–1207
- Henriksen F W, Worning H. The interaction of secretin and pancreozymin on the external pancreatic secretion in dogs. Acta Physiol Scand 1967; 70: 241–249
- Konturek S J, Radecki T, Mikos E, Thor J. The effect of exogenous and endogenous secretin and cholecystokinin on pancreatic secretion in cats. Scand J Gastroenterol 1971; 46: 423–428
- Beglinger C, Grossman M I, Solomon T E. Interaction between stimulants of exocrine pancreatic secretion in dogs. Am J Physiol 1984; 246: G173–179
- Wormsley K G. A comparison of the response to secretin, pancreozymin and a combination of these hormones in man. Scand J Gastroenterol 1969; 4: 413–417
- You C H, Rominger J M, Chey W Y. Potentiation effect of cholecystokinin-octapeptide on pancreatic bicarbonate secretin stimulated by a physiologic dose of secretin in humans. Gastroenterology 1983; 85: 40–45
- You C H, Chey W Y. Atropine abolishes the potentiation effect of secretin and cholecystokinin-octapeptide on exocrine pancreatic secretion in humans. Pancreas 1988; 3: 99–103
- Makovec F, Bani M, Christe R, Revel L, Rovati L A. Differentiation of control and peripheral cholecystokinin receptors by new glutaramic derivatives with cholecystokinin-antagonistic activity. Arnzeim Forsch 1986; 36: 98–102
- Setnikar I, Bani M, Cereda R, et al. Anti-cholecystokinin activities of loxiglumide. Arzneim Forsch 1987; 37: 1168–1171
- Silverman M A, Greenberg R E, Bank S. Cholecystokinin receptor antagonists: a review. Am J Gastroenterol 1987; 82: 703–708
- Konturek S J, Tasler J, Cieszkowski M, Szewczyk K, Hladij M. Effect of cholecystokinin receptor antagonist on pancreatic responses to endogenous gastrin and cholecystokinin and to meal stimuli. Gastroenterology 1988; 94: 1014–1023
- Konturek J W, Konturek S J, Kurek A, Bögdal J, Oleksy J, Rovati L. CCK receptor antagonism by loxiglumide and gallbladder contractions in response to cholecystokinin sham feeding in man. Gut 1989; 30: 1136–1142
- Adler G, Reinshagen M, Kopp I, Rovati L C, Arnold R. Inhibition of stimulated pancreatic secretion in man by a cholecystokinin (CCK) receptor antagonist (CR 1505) [Abstract]. Biomed Res 1988; 9(suppl)59
- Hyden S. A turbidimetric method for the determination of higher polyethylene glycols in biological materials. Kungl Lantbrukshogsk Ann 1956; 22: 139–145
- Konturek S J, Konturek J W, Lamers C B, Tasler J. Role of secretin and CCK in the stimulation of pancreatic secretion in conscious dogs. Effects of atropine and somatostatin. Int J Pancreatol 1987; 2: 223–235
- Valenzuela J E, Lamers C B, Modlin I M, Walsh J H. Cholinergic component in the human pancreatic secretory response to intraintestinal oleate. Gut 1983; 24: 807–811
- Gullo L, Priori P, Pazzilli R, Biliotli G, Martioli G, Barbara L. Pancreatic secretory response to ordinary meals: studies with pure pancreatic juice. Gastroenterology 1988; 94: 428–433
- Singer M V, Solomon T E, Wood J, Grossman M I. Latency of pancreatic enzyme response to intra-duodenal stimulants. Am J Physiol 1980; 238: G23–29
- Bozkurt T, Adler G, Kopp I, Arnold R. Effect of atropine on intestinal phase of pancreatic secretion in man. Digestion 1988; 41: 108–115
- Setnikar I, Bani M, Rovali L C. Protective effect of new glutaramic acid derivatives against experimental pancreatic of mouse and rat [Abstract]. Gastroenterology 1986; 90: 1627
- Niederau C, Liddle R A, Ferrel L D. Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatis. J Clin Invest 1986; 78: 1056–1063